Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
10x Genomics, Inc. (TXG)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Mar-31-23 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Jun-30-21 | Mar-31-21 | Dec-31-20 |
| | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K |
| Revenues | | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Cost of goods sold | | 21.1% | 16.5% | 15.1% | 14.2% | 13.6% | 18.2% | 19.6% |
| Gross profit | | 78.9% | 83.5% | 84.9% | 85.8% | 86.4% | 81.8% | 80.4% |
| Selling, general and administrative | | 55.8% | 53.6% | | 53.1% | 57.5% | 62.8% | |
| Research and development | | 50.5% | 46.9% | 43.2% | 41.3% | 40.7% | 41.9% | 41.3% |
| General and administrative | | | | 14.2% | | | | 18.7% |
| EBITDA | | -22.6% | -12.3% | -6.3% | -4.3% | -7.6% | -18.4% | -24.3% |
| Depreciation | | 4.9% | 4.5% | 4.3% | 4.2% | 4.2% | 4.7% | 4.7% |
| EBIT | | -27.4% | -16.8% | -10.7% | -8.5% | -11.8% | -23.1% | -29.0% |
| Pre-tax income | | -27.7% | -16.9% | -11.0% | -97.2% | -122.0% | -157.7% | -178.8% |
| Income taxes | | 0.9% | 1.0% | 0.9% | 2.0% | 2.2% | 2.5% | 2.8% |
| Net income | | -28.6% | -17.8% | -11.9% | -99.2% | -124.2% | -160.2% | -181.6% |
|